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Abstract: Domoic acid (DA) is one of the best known marine toxins, causative of important neurotoxic
alterations. DA effects are documented both in wildlife and experimental assays, showing that this
toxin causes severe injuries principally in the hippocampal area. In the present study we have
addressed the long-term toxicological effects (30 days) of DA intraperitoneal administration in rats.
Different histological techniques were employed in order to study DA toxicity in heart, an organ
which has not been thoroughly studied after DA intoxication to date. The presence of DA was
detected by immunohistochemical assays, and cellular alterations were observed both by optical
and transmission electron microscopy. Although histological staining methods did not provide any
observable tissue damage, transmission electron microscopy showed several injuries: a moderate
lysis of myofibrils and loss of mitochondrial conformation. This is the first time the association
between heart damage and the presence of the toxin has been observed.
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1. Introduction
Domoic acid (DA) is produced by diatoms, microscopic algae characterized by the presence of a
cell wall made of hydrated silicon dioxide named frustule [1,2]. Diatoms species belong to a group
of microorganisms able to produce marine toxins (phycotoxins), responsible for the appearance of
harmful algal blooms [3,4].
When DA is present at high concentrations in diatoms, this toxin can be bio-accumulated
in shellfish and finfish, causing the poisoning of seabirds, marine mammals or humans [5]. In
the year 1987, DA was responsible for four deaths and the illness of more than 100 people after
consuming blue mussels (Mytilus edulis) harvested in the Cardigan Bay of Prince Edward Island,
Canada [6–8]. The symptomatology comprised three kinds of signs: gastrointestinal (nausea, vomiting,
abdominal cramps and diarrhoea), cardiovascular (unstable blood pressure and arrhythmias), and
neurological signs (disorientation, confusion, headaches, hallucinations, coma, seizures and memory
impairment) [6–8]. Memory impairment led to the denomination of this condition as amnesic shellfish
poisoning (ASP) [6–8] .
DA is a hydrophilic acid whose structure is very similar to kainic acid (KA), being both DA and KA
analogues of glutamate (Glu). Glu is the main excitatory neurotransmitter in the brain, playing a key
role in long-term potentiation [9–11]. DA has high affinity for the glutamate receptors (GluRs) subtypes
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alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and KA receptors [12,13]. The
binding of DA to receptors provokes an increase of calcium (Ca2+) levels, causing the release of Glu to
the extracellular space, and the activation of N-methyl-D-aspartate (NMDA) receptors [14,15]. The
combined action of Glu release and the increase of intracellular (Ca2+) levels produces Reactive Oxide
Species (ROS) and the activation of phospholipases, protein kinase C, proteases, protein-phosphatases,
caspases and nitric oxide synthases [14–17]. The histological consequences of these cellular alterations
comprise astrocytosis, cytoskeletal disarrangement and, finally, cell death.
Numerous in vivo assays, developed principally in mice and rats, have described DA
neuropathological effects. The brain was the main affected tissue, and the lesions were mainly
located in the hippocampal area [17–20], according to the high concentration of KA receptors in this
area [13,21–23]. Other Central Nervous System (CNS) areas were also affected by this neurotoxin, such
as amygdala, olfactory bulb and hypothalamus [24,25] .
Although DA is mainly known due to its neurotoxic effects, besides lesions described in the CNS,
heart affectation was also reported after some DA intoxications. In wildlife the most severe damage
was found in intoxicated California sea lions (Zalophus californianus), consistent with necrosis and
oedemas in the base of the heart, with mild lesions toward the apex [26,27]. Important lesions have
been also described in southern sea otters (Enhydra lutris nereis), comprising of multifocal myocardial
necrosis associated with myocardial haemorrhage [28]. The cardiac alterations caused by DA may be a
possible explanation for the cardiac effects observed in 1987 [6] .
Experimental assays with rats also showed important cardiac damage, that was composed of
cell vacuolization, fibrosis, inflammatory infiltrates (macrophages and leukocytes), and necrosis in
the subendocardium, papillary muscle, and septal regions around the left ventricle [29]. Due to the
presence of GluRs in the heart (concretely they are expressed within the conducting system, in the
cardiac intramural nerve fibers and ganglia cells [30,31]), it seems that DA exerts its cardiotoxic effects
through a direct way. Nevertheless, the in vitro assays did not show any damage in the cardiomyocytes
exposed to the toxin [32]. Hence, DA might exert its influence on heart tissue by an indirect way [29] .
Therefore, the mechanism of action through which the DA exerts its cardiotoxicity remains
unknown. The objective of the present study was to assess the potential cardiotoxic effects of DA,
and to elucidate if this toxin alters cardiac tissue through a direct binding of DA to cardiac GluRs
or by affecting neurons of the limbic system. For this purpose, long-term histological alterations in
heart (30 days) were evaluated, after the intraperitoneal (i.p.) administration of a single dose of DA
in rats. One hour before sacrifice, a new DA dose was administered, in order to detect the toxin by
immunohistochemical analysis.
2. Results
High-performance liquid chromatography-Ultraviolet/Visible (HPLC-UV) analysis revealed no
significant differences between the expected and the actual quantity of DA provided by the supplier
laboratory, guaranteeing that the dose administered was 2.5 mg/kg in all the cases .
After first administration of DA, all rats displayed hypoactivity, head shaking, convulsions and
scratching. During the first 24 h after toxin administration, most of the rats displayed anorexia (n = 8)
and/or adipsia (n = 7). Four of the nine rats died in a period between 5 and 90 min, showing severe
convulsions before death .
After 24 h, adipsia and anorexia were present in many intoxicated rats, one specimen still
displayed a slight scratching and two rats showed hematoporphyrin deposits in eyes and nostrils.
Finally, 72 h after DA administration, only two rats showed anorexia, and one of these specimens
also displayed adipsia. Hematoporphyrin deposits were not visible in any of the rats. Control animals,
injected with physiologic saline solution, did not develop any abnormal symptom. A brief summary
of the symptomatology is presented in Table 1.
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Table 1. Summary of symptoms observed after first DA toxin administration (number of affected
animals/n = 9).












0–24 h 9/9 9/9 9/9 9/9 0/9 7/9 8/9 4/9
24–48 h 0/5 0/5 0/5 1/5 2/5 3/5 4/5 0/5
48–72 h 0/5 0/5 0/5 0/5 0/5 1/5 2/5 0/5
After the second administration of the toxin, scratching, hypoactivity and convulsions were also
noted before sacrifice, being as severe as those observed during the first administration of DA. Due to
the limited time before sacrifice, water or food intake were not taken into account .
Light microscopy of the heart from control (Figure 1A), and treated rats (Figure 1B), including
dead animals after the first DA administration, revealed no histological changes.
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immunoreactivity  in  myocardium.  IHC  with  DA  antibody  1:5000  (original  magnification,×100,   
scale bar = 60 μm). The boxed area shows the positive immunostaining located in the cytoplasm of 
the cardiomyocytes at higher magnifications (original magnification, ×400, scale bar = 20 μm). 
Employing  transmission  electron microscopy  (TEM),  heart  from  control  animals  showed  a 
typical myofibrillar arrangement  (Figure 2A), while cardiomyocyte degeneration was observed  in 
DA‐treated  rats,  with  an  evident  lack  of  integrity  in  the  myofibrils  which  were  in  disarray   
(Figure 2B). All myofibril constituents were affected, and only the Z bands remained undamaged. 
Figure 1. Haem toxylin a d eosin (H & E) stain tions of heart tissue from control and domoic
acid (DA)-treated rats. (A) H & E-stained sections fr trol rats. (or ginal magnification, ˆ40, scale
bar = 200 µm); (B) H & E-stained sections of heart tissue from DA-treated rats showing no visible
damage (original magnification, ˆ40, scale bar = 200 µm); (C) DA Immunohistochemistry (IHC) of the
heart from control rats. The phycotoxin is absent throughout the tissue. IHC with DA antibody 1:5000
(original magnification, ˆ100, scale bar = 60 µm); (D) DA IHC of heart from DA-treated rats showing
immunoreactivity in myocardium. IHC with DA antibody 1:5000 (original magnification,ˆ100, scale
bar = 60 µm). The boxed area shows the positive immunostaining located in the cytoplasm of the
cardiomyocytes at higher magnifications (original magnification, ˆ400, scale bar = 20 µm).
Immunohistochemistry (IHC) against DA did not show traces of the toxin in control animals
(Figure 1C). However, immunoreactivity was observed in DA-treated rats, within cytoplasm of several
randomly distributed groups of cardiomyocytes (Figure 1D).
Employing transmission electron microscopy (TEM), heart from control animals showed a typical
myofibrillar arrangement (Figure 2A), while cardiomyocyte degeneration was observed in DA-treated
rats, with an evident lack of integrity in the myofibrils which were in disarray (Figure 2B). All
myofibril constituents were affected, and only the Z bands remained undamaged. Additionally,
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mitochondria were less electron dense than the same organelles from control specimens, showing
mitochondrial swelling and cristolysis, that is, the lysis and breakage of mitochondrial cristae.
Mitochondrial disposition was also altered; while control specimens showed an organized arrangement
and mitochondria were clearly visible, with a normal round shape (Figure 2C), DA-treated rats
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a  control  specimen  showing  mitochondria  (M)  with  their  usual  shape  and  electron  density;   
(D) Cardiomyocyte from DA treated rat showing degenerated mitochondria (M). These organelles 







Previous  studies  showed  a  similar  symptomatology  in  both  rodent  species:  scratching, 
hypoactivity,  convulsions  and  aggressiveness.  [18,34–43].  When  different  memory  tests  were 








animals were exposed  to  the  toxin. Vranyac‐Tramoundanas et al. reported cardiac damage  in rats 
Figure 2. Transmission Electron Microscopy (TEM) of heart samples from control and DA-treated rats.
(A) Cardiomyocyte from of a control specimen showing the typical arrangement of myofibrils and
mitochondria (M); (B) Ultrastructure of rat cardiac muscle from a DA-treated rat. A moderate lysis
of myofibrils (arrows) and degeneration of mitochondria (M) can be observed; (C) Cardiomyocyte
from a control specimen showing mitochondria (M) with their usual shape and electron density;
(D) Cardiomyocyte from DA treated rat showing degenerated mitochondria (M). These organelles had
lost their habitual rounded shape, they were less electron dense than mitochondria of control animals
and displayed cristolysis.
3. iscussion
Rodents, particularly ice, are the species ost e ployed for assessing toxicity in in vivo assays,
far ore than other organis s such as fishes, cats or onkeys. Rats are still used in so e toxicological
tests, such as the DA toxicological studies. The reasons are that rats are more sensible to DA than mice,
and the lethality observed in rats is closer to that observed in human beings [33].
Previous studies sho ed a si ilar sympto atology in both rodent species: scratching,
hypoactivity, convulsions and aggressiveness. [18,34–43]. When different memory tests were employed,
a short-term memory loss was frequently observed [20,44,45]. Behavioral observations obtained in the
present study concur with the typical symptomatology described in the bibliography. Additionally,
the adipsia, although not as frequent as the other symptoms, has been also observed in our previous
works [46].
There is so e controversy about the cardiac effects elicited after DA administration. Cardiac
da age (concretely, myocardial fibrosis, nuclear hyperplasia and hypertrophy), was described both in
sea otters and sea lions [26–28]; although due to the fact that these ani als ere naturally affected,
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there is a paucity of data about the DA dose able to cause these alterations, or how long the affected
animals were exposed to the toxin. Vranyac-Tramoundanas et al. reported cardiac damage in rats
after DA intrahippocampal and i.p. administration, mainly consistent of cardiomyocite vacuolization,
myofiber loss and inflammatory cell infiltrate [29]. Nevertheless, previously they did not show any
observable damage in isolated cardiomyocytes exposed to the toxin [32] .
Previous studies accomplished in our laboratory involved studying the presence of the toxin or
cardiac damage in rats after short time lapses of exposition [47]. Specimens were sacrificed between
6 and 24 h after toxin i.p. administration [47]. Even so, DA was not detected and no damage was
observed [47]. Therefore, it is possible that DA damage can only be seen some time after toxin
administration (at least more than 24 h).
In the present study, heart samples did not show any histological alteration on light
microscopy. However, immunohistochemical analysis detected DA presence into the cytoplasm
of the cardomyocytes. Hence, the DA was able to reach cardiac tissue after i.p. exposition and it was
able to traverse the cell membrane. This finding suggests that DA could cause disturbances in a direct
way and not just indirectly through the hippocampus and hypothalamic paraventricular nucleus,
which project into the cardiac regulatory centers [32]. The existence of GluRs in heart may explain
the DA affinity for this tissue [30,31]. Nevertheless, despite DA detection in cardiomyocytes, it is
important correlating this fact with the damage produced by the toxin. Even though conventional
staining methods did not show observable injuries in heart tissue, with TEM analysis several injuries
in cardiac cells were detected .
The injuries in mitochondria may have important implications due to their role in energetic
metabolism. Previous in vitro assays performed with cardiac mitochondria isolated from DA-treated
rats revealed alterations in the mitochondrial electron transport complex [32]. A reduction in activity
of complexes I and II–III was noted in those studies after DA incubation. It is known that toxins that
interfere with oxidative phosphorylation or electron transport in mitochondrial cristae will rapidly lead
to ATP depletion and swelling of these organelles, which might affect the proper heart functioning [48].
The mitochondrial dysfunctions are implied in the pathology of a wide variety of common
diseases, including cardiac failure, considering that important decreases in the activity of these
enzymatic complexes were ascertained in cardiac failure [49–51].
Although heart tissue damage caused by DA was mild, the moderate myofibril lysis may affect
the normal functioning of cardiomyocytes, contributing to the cardiac damage .
The moderate myofibril lysis observed may have important implications: DA alteration may
affect the normal functioning of cardiomyocytes and may contribute in some way to the cardiac arrest.
Although heart tissue damage was mild, it may affect, to a certain degree, the normal functioning of
the cardiomyocytes.
Mitochondrial injury and myofibril lysis might be closely related. Bayeva and Ardehali showed
that mitochondria injuries could cause an important ROS generation which, in turn, may cause a
preferential oxidation of myofibrillar proteins and the disruption of actin-myosin interactions [52]. The
subsequent sarcomere alterations may promote the impairment of heart normal function.
This is the first time that correlation between the presence of DA and the observation of cardiac
damage in rats is described. Although the heart damage observed was mild, this damage proves that
DA is able to cause some kind of cardiotoxicity after its administration in rats. Despite the detection
of the toxin in cardiac tissue by immunohistochemical analysis and the presence of a mild damage
by TEM, the possibility that DA exerts its effects through an indirect way, affecting the hippocampus,
cannot be discarded. This brain region is responsible of seizure induction [53], and the alterations in
the hippocampus are able to produce cardiac damage (arrhythmias) [54]. Vranyac-Tramoundanas et al.
observed cardiac damage both in intrahippocampal and intraperitoneal administered rats, and these
injuries were similar among two routes of administration [29]. Additionally, they only detect the
toxin in circulation after i.p. administration, while they did not detect DA after intrahippocampal
administration, discarding the possibility that DA was able to reach the heart [29]. Therefore, the
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damage observed in our experiments may be produced by the affectation of the DA main target, the
hippocampus. Hence, is reasonable to think that DA is able to produce alterations in the cardiac tissue
(directly or by an indirect way).
Cardiac alterations were observed in intoxication in human beings observed in 1987 in Canada.
Afterwards this outbreak, in the year 1991 there were also reports of illness in some people after eating
clams with DA presence [55]. Although no cardiac effects were observed in this second outbreak, this
intoxication was mild compared to Prince Edward Island intoxication. Due to the confirmation of DA
cardiotoxic effects, it would be desirable to continue the study of DA with new approaches or different
doses in order to elucidate the real impact of the cardiac alterations.
4. Conclusions
Based on the present results, we can confirm the affinity of DA for heart tissue; in other
words, this phycotoxin is able to cause injuries in this organ. Although optical microscopy did
not show any observable cardiac damage, TEM showed the loss of myofibrillar arrangement
and severe mitochondrial alterations. Moreover, the presence of DA in heart tissue, detected by
immunohistochemistry, can be correlated with the described injuries.
5. Materials and Methods
5.1. Toxin Analysis
DA (5 mg) was purchased from Sigma-Aldrich (Munich, Germany). To verify the amount of DA
provided in the commercial vial, toxin was analyzed using a Waters Alliance HPLC system 2695 (Waters
Cromatografía, S.A., Cerdanyola del Vallès, Spain) separation module and a Waters 2487 UV/Vis
detector (Waters Cromatografía, S.A., Cerdanyola del Vallès, Spain). Chromatographic separation
was performed on a reversed-phase column C18 Kinetex (2.1 ˆ 100 mm, 2.6 µm, 100 Å, Phenomenex,
Madrid, Spain) protected by a krudkatcher ultra HPLC in-line filter (0.5 µm, Phenomenex). Isocratic
elution 95:5 (A:B) was carried out with a mobile phase A consisting of water with 0.1% acetic acid
and a mobile phase B consisting of acetonitrile. Flow rate was set at 0.4 mL/min and analysis time
at 10 min. Column oven temperature was kept at 40 ˝C, sample manager was kept at 6 ˝C and injection
volume was 10 µL .
Each dilution were injected in triplicate, and control samples including blank of reagents and DA
standard solution (2 µg/mL) were also included within each sample set as quality control samples.
External calibration was performed using the DA certified standard solution CRM-03-DA (CIFGA
Laboratory, Lugo, Spain). Calibration curve range was performed from 0.06 µg/mL to 4.40 µg/mL
through 8 concentration levels and in triplicate analysis. CRM-03-DA certified standard concentration is
integrated by concentrations of DA and C51-epi-domoic acid. Under these chromatographic conditions
DA and C51-epi-domoic acid are resolved, but only DA area is used to calibration, the low percentage
of C51-epi-domoic is assumed as quantization uncertainty.
The EmPower® software (version 3, Waters, Milford, MA, USA, 2010) was used for the entire
HPLC tune, instrument control, data acquisition, and data analysis.
5.2. Animals and Toxin Treatment
A total of 12 adult female Sprague-Dawley rats (weighing 180–215 g, mean weight 200 g) were
employed in this study: 9 experimental and 3 control animals. Animals were individually housed, with
a rodent diet and water provided ad libitum, and maintained at a controlled temperature (23 ˘ 2 ˝C)
and humidity (60%–70%), under a 12 h light: dark cycle, for 1 week before the experiments and
throughout the experimental period.
The dose of DA employed in the 9 treated rats was 2.5 mg/kg, as determined by previous
experiments [44]. The experimental dose was chosen taken into account previous experiments [44],
because it is able to cause injuries being under the LD50.
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DA treated rats (n = 9) were inoculated i.p. with two doses of DA, spaced 30 days. The purpose
of the second DA dose was to be able to detect DA presence in the organ, since this toxin is cleared as
soon as 160 min after the administration [56]. Control animals (n = 3) were inoculated i.p. twice in
the same way with physiological saline solution. The surviving experimental animals were sacrificed
1 h after the second inoculation of toxin with an i.p. overdose of sodium pentobarbital, and control
specimens were sacrificed at the same time.
All the procedures using animals were conducted according to the principles approved by the
Institutional Animal Care Committee of the Universidad de Santiago de Compostela and Xunta
de Galicia (“Pharmacological studies with compounds of natural and synthetic origin”, procedure
approved with code 011/14, dated 1 September 2014). All possible efforts were made to reduce animal
suffering and minimize the number of animals used.
5.3. Behavioural Analysis
Rats were placed in an observation chamber 30 min before DA or saline administration.
Immediately after the first DA administration, the specimens were returned to the observation chamber
and their behaviour was observed for 6 h in a cycle of 5 min on and 10 min off, monitoring all
behavioural responses during three different observation periods: 0 to 24 h, 24 h to 48 h and 48 to
72 h. Four treated rats developed severe clinical signs and died within a period of time between 5
and 90 min after the first DA administration. After second toxin administration, symptoms were also
observed until sacrifice 1 h after DA administration.
5.4. Histopathology and Immunohistochemistry
After sacrifice, necropsy was done and heart was sampled and fixed by immersion in Bouin’s
solution. All samples were embedded in paraffin according to standard laboratory procedures, and
sections of 3 µm thickness were mounted onto silanized slides and dried overnight at 37 ˝C. Four
non-consecutive sections of each animal were employed in each staining or immunohistochemical
assay. The sections were stained with H & E for routine histological analyses .
For immunohistochemical assays, sections were deparaffinized with xylene and rehydrated
through a graded alcohol series. To block peroxidase activity and prevent non-specific staining, 1 h of
pretreatment with Dako Real Peroxidase-Blocking Solution (Dako, Barcelona, Spain) was performed.
After removal of blocking reagents, sections were rinsed 3 times in PBS with 0.005% Tween 20 (Panreac
Química SAU, Barcelona, Spain) and then incubated with a monoclonal primary antibody anti-DA,
courtesy of Dr. Christopher T. Elliott, Institute of Agri-Food and Land Use (IAFLU), School of Biological
Sciences, Queen’s University (Belfast, Northern Ireland, UK). The affinity of this antibody for the toxin
was recently confirmed in our laboratory [57]. As negative controls, we have employed the control
rats, which did not show any immunoreactivity. Additionally, other negative controls were carried out
substituting the primary or the secondary antibody for PBS or an irrelevant polyclonal antibody. As
positive controls we have employed muscular samples from rats of a previous experiment, where the
toxin was intramuscularlly inoculated into the hind limb and the specimens were sacrificed 5 min after
toxin administration.
The dilution employed was 1:5000 and the antibody was incubated overnight. Thereafter, sections
were rinsed 3 times in PBS-Tween 20 and incubated with the secondary antibody solution (Dako
REAL™ EnVisionTM Detection System, Dako, Barcelona, Spain) during 30 min. Samples were washed
3 times with PBS-Tween 20 and revealed with diaminobenzidine (DAB+ Chromogen, Dako, Barcelona,
Spain). Finally, the slides were counterstained with haematoxylin, dehydrated, and permanently
mounted in DPX (BDH Laboratory Supplies, Poole, UK).
5.5. Preparation of Samples for Transmission Electron Microscopy (TEM)
Heart samples (1 mm3) of control and treated specimens were fixed by immersion in 2.5%
glutaraldehyde in 0.1 M cacodylate trihydrate buffer for 30 min at 4 ˝C in an orbital shaker at low
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speed. Fixative was then removed and the samples were rinsed three times with 0.1 M cacodylate
trihydrate buffer. Post-fixation by immersion in 1% OsO4 in 0.1 M cacodylate trihydrate buffer
was performed for 60 min. Finally, after a second rinse fixed tissues were dehydrated in graded
ethanol solutions, including one bath with 70% ethanol and 0.5% uranyl acetate, rinsed in propylene
oxide and embedded in Epon 812 (Momentive Specialty Chemicals Inc., Houston, TX, USA). A Leica
Ultracut UCT ultramicrotome from Leica Microsystems GmbH (Wetzlar, Germany) was used to obtain
ultrathin sections of tissue samples and they were counterstained with uranyl acetate and lead citrate.
Ultrastructural analysis of 1 mm2 samples was performed with a JEOL JEM-1011 Transmission Electron
Microscope (Jeol Ltd., Tokyo, Japan).
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